Long-term outcomes in patients with ipilimumab-naive advanced melanoma in the phase 3 Keynote-006 study who completed pembrolizumab treatment.
Authors
Carlino, MRobert, C
Long, G
Schachter, J
Arance, A
Grob, J
Mortier, L
Daud, A
McNeil, C
MLotem,
Larkin, J
Lorigan, Paul C
Neyns, B
Blank, C
Petrella, T
Hamid, O
Zhou, H
Moreno, BH
Ibrahim, N
Ribas, A
Affiliation
Westmead Hospital, Sydney, AustraliaIssue Date
2017